HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA discourages inclusion of OTC drugs in California VOC reg.

This article was originally published in The Rose Sheet

Executive Summary

CALIFORNIA VOC REDUCTIONS FOR PERSONAL CARE PRODUCTS, for the most part, have "already been accomplished," CTFA said in comments filed with the California Air Resources Board (CARB) on June 19. The letter from CTFA responds to CARB's April 11 list of 93 consumer products (including 26 health and beauty aids) under consideration for regulation by July 1997 as part of the agency's State Implementation Plan (SIP) for setting limits on volatile organic compound emissions. The plan was submitted to the U.S. EPA in November ("The Rose Sheet" Nov. 28, p. 3).

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001789

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel